TY  - JOUR
AU  - Fernández Ruiz, José Javier
AU  - Moreno Martet, Miguel
AU  - Rodríguez Cueto, Carmen Aurora
AU  - Palomo Garo, Cristina
AU  - Gómez Cañas, María
AU  - Valdeolivas, Sara
AU  - Guaza, Carmen
AU  - Romero, Julián
AU  - Guzmán Pastor, Manuel
AU  - Mechoulam, Raphael
AU  - Ramos Atance, José Antonio
PY  - 2011
DO  - 10.1111/j.1476-5381.2011.01365.x
SN  - 0007-1188
SN  - 1476-5381
UR  - https://hdl.handle.net/20.500.14352/93221
T2  - British Journal of Pharmacology
AB  - Cannabinoids are promising medicines to slow down disease progression in neurodegenerative disorders including Parkinson's disease (PD) and Huntington's disease (HD), two of the most important disorders affecting the basal ganglia. Two pharmacological...
LA  - eng
M2  - 1365
PB  - Wiley Online Library
KW  - Basal ganglia
KW  - Cannabinoid signalling system
KW  - Cannabinoids
KW  - CB1 receptors
KW  - CB2 receptors
KW  - Neurodegeneration
KW  - Neuroprotection
TI  - Prospects for cannabinoid therapies in basal ganglia disorders
TY  - journal article
VL  - 163
ER  -